scispace - formally typeset
Open AccessJournal ArticleDOI

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy

Reads0
Chats0
TLDR
In this paper, the genotype/phenotype relationships in 70 affected subjects from 44 apparently unrelated pedigrees of diverse ethnic origin were studied and a significantly higher prevalence of intellectual impairment than those with BSCL1 or BSCLX (p<0.0001, OR 17.0, CI 3.6 to 79.0).
Abstract
Generalised lipodystrophy of the Berardinelli-Seip type (BSCL) is a rare autosomal recessive human disorder with severe adverse metabolic consequences. A gene on chromosome 9 (BSCL1) has recently been identified, predominantly in African-American families. More recently, mutations in a previously undescribed gene of unknown function (BSCL2) on chromosome 11, termed seipin, have been found to be responsible for this disorder in a number of European and Middle Eastern families. We have studied the genotype/phenotype relationships in 70 affected subjects from 44 apparently unrelated pedigrees of diverse ethnic origin. In all subjects, hepatic dysfunction, hyperlipidaemia, diabetes mellitus, and hypertrophic cardiomyopathy were significant contributors to morbidity with no clear differences in their prevalence between subjects with BSCL1 or BSCL2 and those with evidence against cosegregation with either chromosome 9 or 11 (designated BSCLX). BSCL2 appears to be a more severe disorder than BSCL1 with a higher incidence of premature death and a lower prevalence of partial and/or delayed onset of lipodystrophy. Notably, subjects with BSCL2 had a significantly higher prevalence of intellectual impairment than those with BSCL1 or BSCLX (p<0.0001, OR 17.0, CI 3.6 to 79.0). The higher prevalence of intellectual impairment and the increased risk of premature death in BSCL2 compared to BSCL1 emphasise the importance of molecular diagnosis of this syndrome and have clear implications for genetic counselling.

read more

Citations
More filters
Journal ArticleDOI

Diabetes, Obesity, and the Brain

TL;DR: This work has shown that adaptive changes occur that promote energy homeostasis and the maintenance of blood glucose levels in the normal range and are implicated in the link between obesity and type 2 diabetes.
Journal ArticleDOI

Acquired and Inherited Lipodystrophies

TL;DR: This review focuses on the clinical features, underlying pathogenetic mechanisms, and management of various types of acquired and inherited lipodystrophies.
Journal ArticleDOI

Lipodystrophies: Genetic and Acquired Body Fat Disorders

TL;DR: The most prevalent subtype of acquired lipodystrophy currently occurs with prolonged duration of protease inhibitor-containing, highly-active antiretroviral therapy in HIV-infected patients.
Journal ArticleDOI

Balancing the fat: lipid droplets and human disease.

TL;DR: New insights into LD biology and LD protein functions shed new light on mechanisms underlying metabolic pathologies and will likely provide opportunities for treatment of diseases associated with too much or too little fat.
References
More filters
Journal ArticleDOI

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.

TL;DR: As LMNA is ubiquitously expressed, the finding of site-specific amino acid substitutions in PLD, EDMD–AD and CMD1A reveals distinct functional domains of the lamin A/C protein required for the maintenance and integrity of different cell types.
Journal ArticleDOI

Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy

TL;DR: DNA sequencing of LMNA in five Canadian FPLD probands indicated that each had a novel missense mutation, R482Q, which co-segregated with the F PLD phenotype and was absent from 2000 normal alleles, which suggests that LMNA mutations could underlie other diseases characterized by tissue type- and anatomical site-specific cellular degeneration.
Journal ArticleDOI

An undiagnosed endocrinometabolic syndrome: report of 2 cases.

TL;DR: 2 cases of a syndrome which does not seem to fit into any of the known clinical pictures are observed, with an acromegaloid gigantism, hepatosplenomegaly, fatty infiltration of the liver, hyperlipemia, hyperproteinemia, and disturbed carbohydrate metabolism.
Journal ArticleDOI

Generalized lipodystrophy, congenital and acquired (lipoatrophy)

M Seip, +1 more
- 01 Jun 1996 - 
TL;DR: In this article, a longitudinal study was conducted on seven patients with congenital generalized lipodystrophy, and one patient with acquired generalized lipodysplasia, and published papers on these subjects.
Related Papers (5)